0.39
+0.0301(+8.48%)
Currency In USD
Address
75 Shoreway Road
San Carlos, CA 94070
United States of America
Phone
650-931-6236
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11
First IPO Date
February 22, 2021
| Name | Title | Pay | Year Born |
| Dr. Xiaodong Yang M.D., Ph.D. | Chief Executive Officer & Director | 532,989 | 1961 |
| Mr. Francis W. Sarena | Pres & Chief Operating Officer | 474,193 | 1971 |
| Dr. Frank J. Hsu M.D. | Chief Medical Officer | 520,920 | 1961 |
| Mr. William E. Duke Jr. | Chief Financial Officer | 0 | 1972 |
| Ms. Amy Wong | Senior Vice President of Fin. & Operations | 0 | 1966 |
| Dr. Jason Wright Ph.D. | Senior Vice President of CMC | 0 | N/A |
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
